These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
559 related articles for article (PubMed ID: 25487075)
1. Preferential occurrence of spliceosome mutations in acute myeloid leukemia with preceding myelodysplastic syndrome and/or myelodysplasia morphology. Cho YU; Jang S; Seo EJ; Park CJ; Chi HS; Kim DY; Lee JH; Lee JH; Lee KH; Koh KN; Im HJ; Seo JJ; Park SH; Park YM; Lee JK Leuk Lymphoma; 2015; 56(8):2301-8. PubMed ID: 25487075 [TBL] [Abstract][Full Text] [Related]
2. Targeted Next-Generation Sequencing in Myelodysplastic Syndrome and Chronic Myelomonocytic Leukemia Aids Diagnosis in Challenging Cases and Identifies Frequent Spliceosome Mutations in Transformed Acute Myeloid Leukemia. Reinig E; Yang F; Traer E; Arora R; Brown S; Rattray R; Braziel R; Fan G; Press R; Dunlap J Am J Clin Pathol; 2016 Apr; 145(4):497-506. PubMed ID: 27124934 [TBL] [Abstract][Full Text] [Related]
3. ASXL1 mutation as a surrogate marker in acute myeloid leukemia with myelodysplasia-related changes and normal karyotype. Prats-Martín C; Burillo-Sanz S; Morales-Camacho RM; Pérez-López O; Suito M; Vargas MT; Caballero-Velázquez T; Carrillo-Cruz E; González J; Bernal R; Pérez-Simón JA Cancer Med; 2020 Jun; 9(11):3637-3646. PubMed ID: 32216059 [TBL] [Abstract][Full Text] [Related]
4. The prognostic impact of mutations in spliceosomal genes for myelodysplastic syndrome patients without ring sideroblasts. Kang MG; Kim HR; Seo BY; Lee JH; Choi SY; Kim SH; Shin JH; Suh SP; Ahn JS; Shin MG BMC Cancer; 2015 Jun; 15():484. PubMed ID: 26115659 [TBL] [Abstract][Full Text] [Related]
5. Role of ASXL1 and TP53 mutations in the molecular classification and prognosis of acute myeloid leukemias with myelodysplasia-related changes. Devillier R; Mansat-De Mas V; Gelsi-Boyer V; Demur C; Murati A; Corre J; Prebet T; Bertoli S; Brecqueville M; Arnoulet C; Recher C; Vey N; Mozziconacci MJ; Delabesse E; Birnbaum D Oncotarget; 2015 Apr; 6(10):8388-96. PubMed ID: 25860933 [TBL] [Abstract][Full Text] [Related]
6. Acute myeloid leukemia or myelodysplastic syndrome with chromosome 17 abnormalities and long-term outcomes with or without hematopoietic stem cell transplantation. Britt A; Mohyuddin GR; McClune B; Singh A; Lin T; Ganguly S; Abhyankar S; Shune L; McGuirk J; Skikne B; Godwin A; Pessetto Z; Golem S; Divine C; Dias A Leuk Res; 2020 Aug; 95():106402. PubMed ID: 32590108 [TBL] [Abstract][Full Text] [Related]
7. Acute myeloid leukemia with myelodysplasia-related changes diagnosed with multilineage dysplasia alone demonstrates a superior clinical outcome. Jiang G; Capo-Chichi JM; Liu A; Atenafu EG; Guo R; Tierens A; Minden MD; Chang H Hum Pathol; 2020 Oct; 104():117-126. PubMed ID: 32798550 [TBL] [Abstract][Full Text] [Related]
8. Clinicopathologic characterisation of myeloid neoplasms with concurrent spliceosome mutations and myeloproliferative-neoplasm-associated mutations. Liu YC; Illar GM; Bailey NG J Clin Pathol; 2020 Nov; 73(11):728-736. PubMed ID: 32217616 [TBL] [Abstract][Full Text] [Related]
9. Impact of allogeneic hematopoietic cell transplant in patients with myeloid neoplasms carrying spliceosomal mutations. Hamilton BK; Visconte V; Jia X; Tabarroki A; Makishima H; Hasrouni E; Abounader D; Kalaycio M; Sekeres MA; Sobecks R; Duong Liu H; Bolwell B; Maciejewski JP; Copelan E; Tiu RV Am J Hematol; 2016 Jun; 91(4):406-9. PubMed ID: 26799334 [TBL] [Abstract][Full Text] [Related]
10. Multilineage dysplasia (MLD) in acute myeloid leukemia (AML) correlates with MDS-related cytogenetic abnormalities and a prior history of MDS or MDS/MPN but has no independent prognostic relevance: a comparison of 408 cases classified as "AML not otherwise specified" (AML-NOS) or "AML with myelodysplasia-related changes" (AML-MRC). Miesner M; Haferlach C; Bacher U; Weiss T; Macijewski K; Kohlmann A; Klein HU; Dugas M; Kern W; Schnittger S; Haferlach T Blood; 2010 Oct; 116(15):2742-51. PubMed ID: 20581309 [TBL] [Abstract][Full Text] [Related]
11. Outcomes of acute myeloid leukemia with myelodysplasia related changes depend on diagnostic criteria and therapy. Montalban-Bravo G; Kanagal-Shamanna R; Class CA; Sasaki K; Ravandi F; Cortes JE; Daver N; Takahashi K; Short NJ; DiNardo CD; Jabbour E; Borthakur G; Naqvi K; Issa GC; Konopleva M; Khoury JD; Routbort M; Pierce S; Do KA; Bueso-Ramos C; Patel K; Kantarjian H; Garcia-Manero G; Kadia TM Am J Hematol; 2020 Jun; 95(6):612-622. PubMed ID: 32112433 [TBL] [Abstract][Full Text] [Related]
12. Cell-lineage level-targeted sequencing to identify acute myeloid leukemia with myelodysplasia-related changes. Yokoyama K; Shimizu E; Yokoyama N; Nakamura S; Kasajima R; Ogawa M; Takei T; Ito M; Kobayashi A; Yamaguchi R; Imoto S; Miyano S; Tojo A Blood Adv; 2018 Oct; 2(19):2513-2521. PubMed ID: 30282643 [TBL] [Abstract][Full Text] [Related]
13. Patterns of lower risk myelodysplastic syndrome progression: factors predicting progression to high-risk myelodysplastic syndrome and acute myeloid leukemia. Jain AG; Ball S; Aguirre L; Al Ali N; Kaldas D; Tinsley-Vance S; Kuykendall A; Chan O; Sweet K; Lancet JE; Padron E; Sallman DA; Komrokji R Haematologica; 2024 Jul; 109(7):2157-2164. PubMed ID: 38299605 [TBL] [Abstract][Full Text] [Related]
14. Impact of single versus multiple spliceosome mutations on myelodysplastic syndrome. Nagehan P; Sabbir M; Song J; Mohammad H J Clin Exp Hematop; 2023; 63(3):173-176. PubMed ID: 37766563 [TBL] [Abstract][Full Text] [Related]
15. The changing mutational landscape of acute myeloid leukemia and myelodysplastic syndrome. Larsson CA; Cote G; Quintás-Cardama A Mol Cancer Res; 2013 Aug; 11(8):815-27. PubMed ID: 23645565 [TBL] [Abstract][Full Text] [Related]
16. Characteristics of acute myeloid leukemia with myelodysplasia-related changes: A retrospective analysis in a cohort of Chinese patients. Xu XQ; Wang JM; Gao L; Qiu HY; Chen L; Jia L; Hu XX; Yang JM; Ni X; Chen J; Lü SQ; Zhang WP; Song XM Am J Hematol; 2014 Sep; 89(9):874-81. PubMed ID: 24861848 [TBL] [Abstract][Full Text] [Related]
17. FLT3 and NPM1 mutations in myelodysplastic syndromes: Frequency and potential value for predicting progression to acute myeloid leukemia. Bains A; Luthra R; Medeiros LJ; Zuo Z Am J Clin Pathol; 2011 Jan; 135(1):62-9. PubMed ID: 21173125 [TBL] [Abstract][Full Text] [Related]
18. Mutations in the Spliceosomal Machinery Genes SRSF2, U2AF1, and ZRSR2 and Response to Decitabine in Myelodysplastic Syndrome. Hong JY; Seo JY; Kim SH; Jung HA; Park S; Kim K; Jung CW; Kim JS; Park JS; Kim HJ; Jang JH Anticancer Res; 2015 May; 35(5):3081-9. PubMed ID: 25964599 [TBL] [Abstract][Full Text] [Related]
19. MLL gene amplification in acute myeloid leukemia and myelodysplastic syndromes is associated with characteristic clinicopathological findings and TP53 gene mutation. Tang G; DiNardo C; Zhang L; Ravandi F; Khoury JD; Huh YO; Muzzafar T; Medeiros LJ; Wang SA; Bueso-Ramos CE Hum Pathol; 2015 Jan; 46(1):65-73. PubMed ID: 25387813 [TBL] [Abstract][Full Text] [Related]